Armistice Capital, LLC Ptc Therapeutics, Inc. Transaction History
Armistice Capital, LLC
- $7.08 Billion
- Q4 2024
A detailed history of Armistice Capital, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 6,378,000 shares of PTCT stock, worth $307 Million. This represents 4.07% of its overall portfolio holdings.
Number of Shares
6,378,000
Previous 7,234,898
11.84%
Holding current value
$307 Million
Previous $268 Million
7.26%
% of portfolio
4.07%
Previous 4.46%
Shares
25 transactions
Others Institutions Holding PTCT
# of Institutions
263Shares Held
72.6MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$442 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$375 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$356 Million5.44% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.29MShares$158 Million0.24% of portfolio
-
Camber Capital Management LP Boston, MA3.2MShares$154 Million3.34% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.45B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...